Response to Naunton and Duyvendak re "Appropriate use of antiplatelets: Is prescription in daily practice influenced by the global cardiovascular risk?"

Lara Monesi; Fausto Avanzini; Maria Carla Roncaglioni

doi:10.1007/s00228-005-0048-0

Response to Naunton and Duyvendak re "Appropriate use of antiplatelets: Is prescription in daily practice influenced by the global cardiovascular risk?"

Lara Monesi, Fausto Avanzini, Maria Carla Roncaglioni

Istituto di Ricerche Farmacologiche "Mario Negri"

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	79-80
Number of pages	2
Journal	European Journal of Clinical Pharmacology
Volume	62
Issue number	1
DOIs	https://doi.org/10.1007/s00228-005-0048-0
Publication status	Published - Jan 2006

ASJC Scopus subject areas

Pharmacology (medical)
Pharmacology, Toxicology and Pharmaceutics(all)

Access to Document

10.1007/s00228-005-0048-0

Cite this

@article{dee2ed1fcab042f5b4a1c24b139e848d,

title = "Response to Naunton and Duyvendak re {"}Appropriate use of antiplatelets: Is prescription in daily practice influenced by the global cardiovascular risk?{"}",

author = "Lara Monesi and Fausto Avanzini and Roncaglioni, {Maria Carla}",

year = "2006",

month = jan,

doi = "10.1007/s00228-005-0048-0",

language = "English",

volume = "62",

pages = "79--80",

journal = "European Journal of Clinical Pharmacology",

issn = "0031-6970",

publisher = "Springer Verlag",

number = "1",

}

TY - JOUR

T1 - Response to Naunton and Duyvendak re "Appropriate use of antiplatelets

T2 - Is prescription in daily practice influenced by the global cardiovascular risk?"

AU - Monesi, Lara

AU - Avanzini, Fausto

AU - Roncaglioni, Maria Carla

PY - 2006/1

Y1 - 2006/1

UR - http://www.scopus.com/inward/record.url?scp=30844469324&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30844469324&partnerID=8YFLogxK

U2 - 10.1007/s00228-005-0048-0

DO - 10.1007/s00228-005-0048-0

M3 - Article

AN - SCOPUS:30844469324

VL - 62

SP - 79

EP - 80

JO - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

SN - 0031-6970

IS - 1

ER -

Response to Naunton and Duyvendak re "Appropriate use of antiplatelets: Is prescription in daily practice influenced by the global cardiovascular risk?"

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this